Abstract
Background and objectives
Materials and methods
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Transfusion and Apheresis ScienceReferences
FDA . Fatalities reported to FDA following blood collection and transfusion annual summary for Fiscal year 2018. Cited 2021 Nov 16. Available from 〈https://www.fda.gov/media/136907/download〉.
- Bacterial contamination.in: Popovsky M.A. Transfusion reactions. 4th ed. (MD). Bethesda, American Association of Blood Banks, 2012: 153-189
Swissmedic. Haemovigilance annual reports 2006–2019. Cited 2021 Aug 22. Available from 〈https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/market-surveillance/haemovigilance.html〉.
Canadian Blood Services. Circular of information for the use of human blood components. Cited 2021 Sep 23. Available from 〈https://www.blood.ca/sites/default/files/Pooled_Platelets_LR_CPD_Apheresis_Platelets_0.pdf〉.
- Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-drived platelets: a pilot study.Transfusion. 2021; 61: 1562-1569
- Routine bacterial screening of platelet concentrates by flow cytometry and its impact on product safety and supply.Vox Sang. 2015; 108: 209-218
- Detection of bacterial contamination of apheresis platelets in a Chines Blood Center.Transfus Med. 2009; 19: 357-362
- Rapid detection of bacterial contamination in platelet concentrates, by polymerase chain reaction and DNA sequencing in comparison to conventional automated culture.Int J Curr Microbiol Appl Sci. 2014; 3: 38-52
- Platelet enhancement of bacterial growth during room temperature storage: mitigation through refrigeration.Transfusion. 2019; 59: 1479-1489
- In vitro bactericidal activity of equine platelet concentrates, platelet poor plasma, and plasma against methicillin-resistant Staphylococcus aureus.Arch Med Vet. 2011; 43: 155-161
- Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study.PLoS One. 2014; 9e107813
- Platelets: at the nexus of antimicrobial defence.Nat Rev Microbiol. 2014; 12: 426-437
- Antimicrobial peptides from human platelets.Infect Immun. 2002; 70: 6524-6533
- Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates.Transfusion. 2018; 58: 2013-2021
- Biofilm matrix and cell wall modification during biofilm formation might confer Staphylococcus epidermidis advantages growth in platelets. Abstract 4C-S28-02.Vox Sang. 2017; 112: S63-S64
- Structural and functional dynamics of Staphylococcus aureus biofilms and biofilm matrix proteins on different clinical materials.Microorganisms. 2019; 7: 584
- Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects.Front Cell Infect Microbiol. 2015; 5: 7
- Production of icaADBC-encoded polysaccharide intercellular adhesin and therapeutic failure in pediatric patients with staphylococcal device-related infections.BMC Infect Dis. 2010; 10: 68
- The staphylococcal expolysaccharide PIA-biosynthesis and role in biofilm formation, colonization, and infection.Comput Struct Biotechnol J. 2020; 18: 3324-3334
- A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB.J Bacteriol. 2008; 190: 3835-3850
- Protein-based biofilm matrices in Staphylococci.Front Cell infect Microbiol. 2014; 4: 171
- Expression of the biofilm-associated genes in methicillin-resistant Staphylococcus aureus in biofilm and planktonic conditions.Int J Mol Sci. 2018; 19: 3487
- The elastin-binding protein of Staphylococcus aureus (EbpS) is expressed at the cell surface as an integral membrane protein and not as a well-associated protein.J Biol Chem. 2002; 277: 243-250
- Use of multiplex PCR to identify Staphylococcus aureus adhesins involved in human hematogenous infections.J Clin Microbiol. 2003; 41: 4465-4467
- Identification of residues in the Staphylococcus aureus fibrinogen-binding MSCRAMM clumping factor A (ClFA) that are important for ligand binding.J Biol Chem. 2001; 276: 2466-2473
- Characterization of the growth dynamics and biofilm formation of Staphylococcus epidermidis strains isolated from contaminated platelet units.J Med Microbiol. 2014; 63: 844-891
- Enhanced pathogenicity of biofilm-negative Staphylococcus epidermidis isolated from platelet preparations.Transfusion. 2014; 54: 461-470
- Biofilm-associated accumulation-associated (Aap): A contributing factor to the predominant growth of Staphylococcus epidermidis in platelet concentrates.Vox Sang. 2019; 114: 28-37
- Analysis of relative gene expression data using real time quantitative PCR and the 2-∆∆Ct method.Methods. 2001; 25: 402-408
- Evaluation of different detection methods of biofilm formation in the clinical isolates.Braz J Infect Dis. 2011; 15: 305-311
- Identification of enolase as a laminin-binding protein on the surface of Staphylococcus aureus.Microbes Infect. 2004; 6: 604-608
- Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer?.Microbiology. 2005; 151: 2465-2475
- Platelets and infections – complex interactions with bacteria.Front Immunol. 2015; 6: 82
- Quantitative PCR analysis of genes expressed during biofilm development of methicillin resistant Staphylococcus aureus (MRSA).Infect Genet Evol. 2013; 18: 106-112
- Bacterial contamination of platelets for transfusion: strategies for prevention.Crit Care. 2018; 22: 271
- UV light-emitting diode (UV-LED) at 265 nm as a potential light source for disinfection human platelet concetrates.PLoS One. 2021; 16e0251650
- Flow path system of ultraviolet C irradiation from xenon flash to reduce bacteria survival in platelet products containing a platelet additive solution.Transfusion. 2020; 60: 1050-1059
- Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology.Blood Transfus. 2017; 15: 357-364
- Pathogen inactivation efficacy of Mirasol PRT System and Intercept Blood System for non-leucoreduced platelet-rich plasma-derived platelets suspended in plasma.Vox Sang. 2014; 107: 254-260